Solventum Corporation balance sheet SOLV

Annual Quarterly

As of Jun 30, 2026, Solventum Corporation had total assets of $14.2 billion and total liabilities of $9.4 billion. Total assets were down 5.5% from a year earlier. Stockholders' equity was $4.8 billion. It held $403.0 million in cash and investments against $5.3 billion of total debt, net debt of $4.9 billion. The current ratio, current assets divided by current liabilities, was 1.02.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Assets
Cash	403 -18.1%	561 +5.1%	878 +15.2%	1,642 +112.7%	492 -45.2%	534 -46.4%	762	772
Cash and investments	403 -18.1%	561 +5.1%	878 +15.2%	1,642 +112.7%	492 -45.2%	534 -46.4%	762	772
Receivables	1,310 +23.0%	1,059 +14.4%	1,034 -1.0%	1,019 -7.8%	1,065 +3.6%	926 -24.1%	1,044	1,105
Inventory	1,040 +8.1%	1,089 +25.8%	1,066 +10.5%	1,049 +10.1%	962 +7.0%	866 -3.9%	965	953
Total current assets	3,741 +16.6%	3,583 +17.4%	3,859 +18.8%	4,407 +31.4%	3,208 -4.6%	3,053 -9.1%	3,249	3,354
Property and equipment, net	1,565	1,543	—	—	—	—	—	—
Goodwill	5,626 +6.7%	5,626 +12.7%	5,704 -10.6%	5,260 -20.2%	5,274 -18.2%	4,991 -22.8%	6,377	6,592
Total assets	14,243 -5.5%	14,097 -3.0%	14,294 -1.1%	13,973 -5.2%	15,074 +3.4%	14,527 -1.3%	14,457	14,745
Liabilities and equity
Accounts payable	701 +9.0%	699 +15.7%	687 +11.2%	669 +19.5%	643 +29.9%	604 +2.9%	618	560
Total current liabilities	3,663 +39.8%	3,346 +30.4%	3,136 +16.0%	2,938 +1.2%	2,620 +1.9%	2,566 +38.4%	2,703	2,904
Total liabilities	9,443 -17.4%	9,128 -19.0%	9,245 -19.6%	8,987 -22.2%	11,429 -2.4%	11,265 +3.7%	11,498	11,553
Stockholders' equity	4,800 +31.7%	4,969 +52.3%	5,049 +70.6%	4,986 +56.2%	3,645 +27.1%	3,262 -15.3%	2,959	3,192
Debt
Debt due within a year	506	505 +405.0%	—	—	—	100	200	300
Long-term debt	4,573 -41.5%	4,575 -41.4%	5,035 -35.5%	5,137 -34.2%	7,815 -5.9%	7,813 -5.9%	7,810	7,809
Lease liabilities	209	208	212 +22.5%	—	—	—	173	—
Total debt	5,288 -32.3%	5,288 -33.2%	5,247 -35.9%	5,137 -36.7%	7,815 -5.9%	7,913 -4.7%	8,183	8,109
Net cash	-4,885 +33.3%	-4,727 +35.9%	-4,369 +41.1%	-3,495 +52.4%	-7,323 +1.2%	-7,379 -1.0%	-7,421	-7,337
Ratios
Current ratio	1.02x	1.07x	1.23x	1.50x	1.22x	1.19x	1.20x	1.15x
Debt to equity	1.10x	1.06x	1.04x	1.03x	2.14x	2.43x	2.77x	2.54x
Debt to EBITDA	2.05x	2.03x	1.97x	1.89x	5.96x	5.85x	5.14x	—
Return on equity	29.88%	28.82%	30.82%	30.57%	10.43%	11.62%	16.19%	—
Return on assets	10.07%	10.16%	10.89%	10.91%	2.52%	2.61%	3.31%	—
Book value per share	28.22	28.63	29.10	28.75	21.02	18.85	17.13	18.48

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: SOLV (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Eagan, MN
SEC filer status: Large accelerated filer
SEC CIK: 1964738
Former names: 3M Health Care Co (until Feb 9, 2024)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.